MétaCan
Menu
← Back to cohort
Record W4396995835 · doi:10.1681/asn.20213210s137b

The Comparative Effectiveness and Safety of Direct Oral Anticoagulant (DOAC) and Warfarin Initiation in Adults with Atrial Fibrillation (AF) by eGFR Category

2021· article· en· W4396995835 on OpenAlexaboutno aff
Min Jun, Martin Gallagher

Bibliographic record

VenueJournal of the American Society of Nephrology · 2021
Typearticle
Languageen
FieldMedicine
TopicAtrial Fibrillation Management and Outcomes
Canadian institutionsnot available
Fundersnot available
KeywordsAtrial fibrillationWarfarinMedicineOral anticoagulantInternal medicineAnticoagulantCardiology

Abstract

fetched live from OpenAlex

Background: There is ongoing uncertainty regarding the risk-benefit ratio of DOACs in patients with AF and CKD. Methods: We conducted an international multicenter cohort study(2011-2018) using healthcare data from 5 jurisdictions across Australia (666 participants of the 45 and Up Study [among 267153 recruited in 2006-09] with data linked to hospital/laboratory data [by CHeReL] and the Medicare Benefits Schedule and Pharmaceutical Benefits Scheme data provided by Services Australia; all linked data accessed via SURE) and Canada (73876 patients in AB,BC,MB,ON; record linkage of provincial administrative/laboratory data). We propensity score matched adults with a new dispensation of a DOAC (rivaroxaban, apixaban, dabigatran) or warfarin, who had AF and a recorded eGFR grouped as ≥60,45-59,30-44, <30ml/min/1.73m2. Chronic dialysis or kidney transplant recipients were excluded. We assessed 2 composite outcomes within 1 year of initiating either therapy: ischemic (all-cause death, ischemic stroke or TIA) and bleeding (intracranial, gastrointestinal or other). We used Cox regression to estimate the hazard ratios (HRs[95%CI]) of outcomes across eGFR categories and summarized centre data in random effects meta-analysis. Results: A total of 74542 eligible patients were included, among whom there were 6923(9.2%) ischemic and 1572(2.1%) bleeding events recorded. Across eGFR groups, DOAC initiation was associated with lower or similar risk for the ischemic outcome compared with warfarin initiation (pooled HRs[95%CI] for eGFR groups: 0.74[0.69-0.79], 0.76[0.54-1.07], 0.68[0.61-0.75] and 0.86[0.76-0.98], respectively). Similar results were observed for bleeding (0.75[0.65-0.86], 0.81[0.65-1.01], 0.82 [0.66-1.02], 0.71[0.52-0.99], respectively). There was no evidence of heterogeneity across jurisdictions except for eGFR 45-59ml/min/1.73m2 for the ischemic outcome (I2=77%). Conclusions: In this cohort of AF patients initiating DOAC or warfarin, compared to warfarin, DOAC use was associated with lower or similar risk of both ischemic and bleeding outcomes independent of eGFR. Our results suggest DOAC therapy may have a favourable risk-benefit ratio in AF patients with non-dialysis dependent CKD that is similar to that seen in AF patients with preserved kidney function. Adequately powered randomized trials are needed to confirm these findings. Funding: Government Support - Non-U.S.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.016
metaresearch head score (Gemma)0.029
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.016
Threshold uncertainty score0.086

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0160.029
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.011
Bibliometrics0.0010.001
Science and technology studies0.0000.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.031
GPT teacher head0.320
Teacher spread0.289 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the American Society of Nephrology→Same topicAtrial Fibrillation Management and Outcomes→French-language works237,207→